MedPath

A randomized controlled clinical study of acupuncture combined with medicine in the treatment of ovarian hypofunctio

Phase 1
Conditions
Ovarian dysfunction
Registration Number
ITMCTR2000003595
Lead Sponsor
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

The DOR diagnostic criteria of western medicine and the diagnostic criteria of spleen and kidney deficiency syndrome of Traditional Chinese medicine, the patients who had regular menstruation in the past, had not used estrogen, Traditional Chinese medicine and acupuncture treatment in the recent 3 months, volunteered to participate in this study and insisted on treatment, and actively cooperated with the follow-up visits, were all included in this study after signing the informed consent.

Exclusion Criteria

1. Aged < 18 years old or > 40 years;
2. Bilateral or unilateral ovariectomy or chemoradiotherapy caused DOR;
3. Chromosomal karyotype abnormality;
4. Congenital or acquired reproductive organ organic diseases and caused menstrual disorders;
5. For patients without menstrual symptoms, infertility caused by male factors, tubal factors, organic diseases of the reproductive organs and other factors other than THE DOR should be excluded;
6. Patients with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic systems, mental diseases and breast tumors;
7. Take estrogen, traditional Chinese medicine and acupuncture treatment history or history of amenorrhea within 3 months;
8. Is allergic to a variety of drugs or known to be allergic to the composition of the drug;
9. Pet-name failure to take prescribed drugs or to follow up regularly, unable to determine the efficacy or incomplete data affecting the efficacy.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
AMH;Pregnancy rate, abortion rate;
Secondary Outcome Measures
NameTimeMethod
T, FSH, LH, E2, PRL;AFC and ovarian volume;TCM symptom and sign score;
© Copyright 2025. All Rights Reserved by MedPath